BrainStorm Cell Therapeutics
BCLI
#10401
Rank
C$9.17 M
Marketcap
C$0.83
Share price
0.00%
Change (1 day)
-62.82%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of June 2025 : C$1.14 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has C$1.14 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.26 M-84.44%
2023-12-31C$1.72 M-57.4%
2022-12-31C$4.04 M-85.62%
2021-12-31C$28.15 M-47.34%
2020-12-31C$53.47 M7095.25%
2019-12-31C$0.74 M-92.28%
2018-12-31C$9.62 M-1.32%
2017-12-31C$9.75 M-27.37%
2016-12-31C$13.42 M-39.34%
2015-12-31C$22.13 M123.3%
2014-12-31C$9.91 M165.8%
2013-12-31C$3.72 M-8.22%
2012-12-31C$4.06 M107.72%
2011-12-31C$1.95 M2004.15%
2010-12-31C$0.09 M8735.09%
2009-12-31C$0 M-56.73%
2008-12-31C$0 M-97.17%
2007-12-31C$0.08 M22.81%
2006-12-31C$0.06 M
2006-03-31C$0.34 M-46.55%
2005-03-31C$0.63 M10514.69%
2004-03-31C$0 M-59.01%
2003-03-31C$0.01 M-74.54%
2002-03-31C$0.05 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
C$10.18 B 891,768.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$1.33 B 116,712.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$1.71 B 150,020.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$5.48 B 480,531.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$4.79 M 319.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA